Ascendis Pharma A/S vs Teucrium Wheat Fund — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Teucrium Wheat Fund trades at $24.15. Which is the better fit depends on your goals.
| ASND | WEAT | |
|---|---|---|
Market Cap | $16.67B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $277.18 | $26.00 |
52-Week Low | $189.74 | $19.88 |
Enterprise Value | $17.04B | — |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →